medigraphic.com
ISSN 1561-3003 (Electronic)

2016, Number 1

<< Back Next >>

Rev Cubana Hig Epidemiol 2016; 54 (1)

Challenges of the tuberculosis control program, Colombia, 2011-2013

Muñoz SAI, Saavedra CCJ, López RLV, Loaiza ACE, Cruz MOA, Hernández GY

Language: Spanish
References: 27
Page: 37-46
PDF size: 167.24 Kb.


ABSTRACT

Introduction: Mortality due to tuberculosis is an indicator of the actions included in the TB control program, and guides the taking of decisions by agencies formulating public health policies. On the other hand, the great burden of this condition is a reflection of the living conditions and the health status of people.
Objective: Describe the sociodemographic aspects of the tuberculosis control program with reference to deaths due to the disease in the localities of Los Mártires, Rafael Uribe and Ciudad Bolívar, in Bogotá C.D., from 2011 to 2013.
Methods: A quantitative retrospective descriptive study was conducted whose sources of information were the databases of competent institutions.
Results: Based on the sociodemographic data about patients deceased due to tuberculosis, there was a predominance of elderly people, men, low schooling, and TB-HIV coinfection. Deaths were more common among people on subsidized schemes. It was found that no follow-up had been performed of the bacilloscopies of all the deceased, and that collaborative actions between TB and HIV programs require consolidation.
Conclusions: According to the sociodemographic results obtained, it is necessary to apply a differentiated, comprehensive preventive approach to the TB population. Actions in the TB program should be strengthened, so as to prevent mortality due to this condition. It is also indispensable to set up an information system articulating program control and follow-up actions with the institutions that provide health services, since inconsistencies were found between the data obtained from the various sources analyzed.


REFERENCES

  1. Organización Mundial de la Salud. Global Tuberculosis Report 2014. WHO; 2014 [citado 20 Dic 2014]. Disponible en: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809 eng.pdf?ua = 1

  2. Organización Mundial de la Salud. Global strategy and targets for tuberculosis prevention, care and control after 2015. WHO; 2014 [citado 15 Ene 2015]. Disponible en: http://www.who.int/tb/post2015 TBstrategy.pdf

  3. Instituto Nacional de Salud. Semana epidemiológica número 52 de 2014. Dirección de Vigilancia y Análisis del Riesgo en Salud Pública. 2014 [citado 20 Ene 2014]. Disponible en: http://www.ins.gov.co/boletin-epidemiologico/Boletn Epidemiolgico/2014 Boletin epidemiologico %20semana %2052.pdf

  4. Secretaría Distrital de Salud de Bogotá. Contexto epidemiológico de la tuberculosis en todas las formas 2011 vs. 2014. Datos Preliminares. Colombia: Secretaría Distrital de Salud de Bogotá; 2014.

  5. Organización Mundial de la Salud. Tuberculosis, nota descriptiva 104. WHO; 2014 [citado 20 Ene 2015]. Disponible en: http://www.who.int/mediacentre/factsheets/fs104/es/

  6. Organización Mundial de la Salud. Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud (CIE-10). Washington DC: OPS/OMS; 2003 [citado 24 Oct 2014]. Disponible en: http://ais.paho.org/classifications/Chapters/pdf/Volume2.pdf

  7. Ministerio de Salud y de la Protección Social de Colombia. Resolución 8430 Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. 1993 [citado 18 Sep 2014]. Disponible en: http://www.urosario.edu.co/EMCS/Documentos/investigacion/resolucion 008430 1 993/

  8. Zhang H, Huang F, Chen W, Du X, Zhou MG, Hu J, et al. Estimates of tuberculosis mortality rates in China using the disease surveillance point system, 2004-2010. Biomed Environ Sci. 2012;25(4):483-8.

  9. Fernández M, Jané A, Rodríguez L, Carreras L, García H. Tuberculosis, comportamiento de la mortalidad en pacientes de 60 años de edad o más. Rev Cubana de Medicina Gen Integr. 2012;28(2):55-64.

  10. Kwon Y-S, Kim YH, Song J-U, Jeon K, Ju Ryu Y, Chol J, et al. Risk factors for death during pulmonary tuberculosis treatment in Korea: a multicenter retrospective cohort study. J Korean Med Sci. 2014;29(9):1226-31.

  11. Horne D, Hubbard R, Narita M, Exarchos A, Park D, Goss C. Factors associated with mortality in patients with tuberculosis. BMC Infect Dis. 2010;10(1):258-65.

  12. Magee MJ, Foote M, Maggio DM, Howards PP, Narayan KM, Blumberg HM, et al. Diabetes mellitus and risk of all-cause mortality among patients with tuberculosis in the state of Georgia, 2009-2012. Ann Epidemiol. 2014;24(5):369-75.

  13. Sánchez JJ. Tendencias de mortalidad y riesgo de muerte por tuberculosis pulmonar en las 7 regiones socioeconómicas y los 32 estados de México, 20002009. Arch Bronconeumol. 2015;51(1):16-23.

  14. Nascimento do Prado T, Espinosa A, Mattos de Souza F, Dos Santos Dias E, Fernández LK, Arakaki-Sanchez S, et al. Factors associated with tuberculosis by HIV status in the Brazilian national surveillance system: a cross sectional study. BMC Infect Dis. 2014;14:415.

  15. Meza JA, Sánchez HJ, Enciso GF, Sánchez G. El gradiente socioeconómico de la mortalidad por tuberculosis en México 2004-2008. Población y Salud en Mesoamérica. 2013;10(2):1-15.

  16. García CA, Muñoz AI. Evaluación de indicadores programáticos: la necesidad de un enfoque social de la tuberculosis. Rev Fac Nac Salud Pública. 2014;32(2):76-84.

  17. Drobac PC, Shin SS, Huamani P, Atwood S, Furin J, Franke M, et al. Risk factors for in-hospital mortality among children with tuberculosis: the 25 year experience in Peru. Pediatrics. 2012;130(2):373-9.

  18. Valade S, Raskine L, Aout M, Malissin I, Brun P, Deye N, et al. Tuberculosis in the intensive care unit: a retrospective descriptive cohort study with determination of a predictive fatality score. Can J Infect Dis Med Microbiol. 2012;23(4):173-8.

  19. Burton NT, Forson A, Lurie MN, Kudzawu S, Kwarteng E, Kwara A. Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana. Trans R Soc Trop Med Hyg. 2011;105(12):675-82.

  20. Villa L, Trompa IM, Montes FN, Gómez JG, Restrepo CA. Análisis de la mortalidad por tuberculosis en la ciudad de Medellín, 2012. Biomédica. 2014;34(3):425-32.

  21. Feng JY, Su WJ, Chiu YC, Huang SF, Lin YY, Huang RM, et al. Initial presentations predict mortality in pulmonary tuberculosis patients - a prospective observational study. PloS One. 2011;6(9):1-9.

  22. Albuquerne MF, Batista JL, Alencar RA, Carvalho MS, Nunez GT, Rodrigues LC. Risk factors associated with death in patients who initiate treatment for tuberculosis after two different follow-up periods. Rev Bras Epidemiol. 2009;12(4): 513-22.

  23. Kabali C, Mtei L, Brooks DR, Waddell R, Bakari M, Matee M, et al. Increased mortality associated with treated active tuberculosis in HIV-infected adults in Tanzania. Tuberculosis (Edinb). 2013;93(4):461-6.

  24. Waghmare V, Shaikh A, Pawar K. A hospital based study: mortality among patients of pulmonary tuberculosis. Indian J Forensic Med Pathol. 2013;6(4):181-7.

  25. Bhargava A, Chatterjee M, Jain Y, Chatterjee B, Kataria A, Bhargava M, et al. Nutritional status of adult patients with pulmonary tuberculosis in rural central India and its association with mortality. PloS One. 2013;8(10):e77979.

  26. Giraldo DP, Malacarne J, Correa LC, Sant Anna CC, Bastos LA, Basta PC. Tuberculose em indígenas da Amazonia brasileira: estudo epidemiológico naregiao do Alto Rio Negro. Rev Panam Salud Pública. 2013;33(1):22-9.

  27. Cortés CP, Wehbe FH, McGowan CC, Shepherd BE, Duda SN, Jenkins CA, et al. Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis. PloS One. 2013;8(9):e74057.




2020     |     www.medigraphic.com